Company requirements under Canada's Access to Medicines Regime

To participate in the Regime, a pharmaceutical company must enter into a sales agreement with an eligible importing country for the purchase of a specified amount of an eligible product listed on Schedule 1. A pharmaceutical company must also submit an application for authorization to Canada's Commissioner of Patents. Once the authorization or compulsory licence is issued, there are additional terms and conditions that the company must meet and maintain.

Data and Resources

Additional Info

Field	Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French)	Exigences pour les entreprises : Régime canadien d'accès aux médicaments
Update Frequency	as_needed
Geographic Scope	[]
Criticality Level	[]
Sensitivity Level	unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published	2017-03-29 00:00:00
Open Canada Date Modified
Open Canada Subject	["health_and_safety"]
Open Canada Keywords	{"fr": ["Régime canadien d'accès aux médicaments", "exigences pour les entreprises", "entente commerciale", "licence obligatoire", "pays importateurs admissibles", "produit admissible", "demande d'autorisation auprès du commissaire aux brevets du Canada"], "en": ["Company requirements under Canada's Access to Medicines Regime", "sales agreement", "compulsory licence", "eligible importing country", "eligible product", "application for authorization to Canada's Commissioner of Patents."]}
Open Canada Collection	publication
Principal Organization
Reference Data
Official Source